Goldman Sachs Group Inc Astrazeneca PLC Transaction History
Goldman Sachs Group Inc
- $780 Billion
- Q3 2025
A detailed history of Goldman Sachs Group Inc transactions in Astrazeneca PLC stock. As of the latest transaction made, Goldman Sachs Group Inc holds 13,671,749 shares of AZN stock, worth $1.22 Billion. This represents 0.13% of its overall portfolio holdings.
Number of Shares
13,671,749
Previous 12,012,062
13.82%
Holding current value
$1.22 Billion
Previous $839 Million
24.96%
% of portfolio
0.13%
Previous 0.12%
Shares
24 transactions
Others Institutions Holding AZN
# of Institutions
1,502Shares Held
500MCall Options Held
5.64MPut Options Held
3.2M-
Price T Rowe Associates Inc Baltimore, MD49.1MShares$4.39 Billion0.4% of portfolio
-
Primecap Management CO Pasadena, CA39.9MShares$3.56 Billion2.42% of portfolio
-
Bank Of America Corp Charlotte, NC32.6MShares$2.92 Billion0.18% of portfolio
-
Wellington Management Group LLP Boston, MA32.3MShares$2.89 Billion0.45% of portfolio
-
Capital International Investors Los Angeles, CA25.1MShares$2.24 Billion0.33% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $277B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...